A Dayton-area medical technology firm has recently had its AI-driven image processing and analysis technology cleared by the ...

Millions of people who take medication have vision problems or don’t speak English, making it easy to mix up prescriptions and take the wrong pills. But te ...

Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA ) and certain officers. The class action, filed in ...

President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...

As a visionary, Pharmacist and Founder of NimVax, Dr. Nimit Deocampo wanted to offer even more value to patients after receiving repeated ...

A legal battle is ongoing between John Lydon and photographer Dennis Morris over who owns the copyright in the logo for Public Image Ltd. Following a pre-trial hearing in court last month ...

As of Tuesday, it’s free. Google is bringing all its AI features to its Workspace app at no extra cost as it continues to race Microsoft, OpenAI, and others to build the AI-powered office suite ...

I want to show you the top 5 royalty free music website for YouTube. And if you are not familiar with the rules behind using music on YouTube, I’ll give you a quick overview, so you don’t get ...

Containing 10,000+ items, the Public Domain Image Archive is a vast trove of illustrations, prints, scans, and more, all downloadable and free for use. The database offers a functional search that ...

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China Hubei Shizhen Laboratory, Hubei University ...

This time, it slashed its full-year EPS guidance to $2.80-$2.95 due to challenging pharmacy industry trends and a weak consumer environment. Almost everything that could go wrong for Walgreens ...

The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely ...